未破裂颅内梭形动脉瘤的瘤壁强化、动脉粥样硬化蛋白与动脉瘤大小可能相关
本横断面研究纳入71例未破裂颅内梭形动脉瘤患者,行高分辨率磁共振成像和动脉粥样硬化蛋白检测,发现他汀使用和载脂蛋白B水平是瘤壁强化的独立预测因素,且瘤壁强化及CRstalk与动脉瘤最大径呈正相关。
要点
- CRstalk>0.60可提示颅内梭形动脉瘤瘤壁强化。
- 载脂蛋白B水平与他汀使用是瘤壁强化的独立预测因素。
- 瘤壁强化及CRstalk与动脉瘤最大径呈正相关。
局限性
- 横断面研究设计无法确定因果关系。
- 单中心研究,样本量有限(71例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This cross-sectional study aimed to investigate the associations between aneurysm wall enhancement (AWE), atherosclerotic protein levels, and aneurysm size in unruptured intracranial fusiform aneurysms (IFAs).
METHODS: Patients with IFAs underwent high-resolution magnetic resonance imaging (HR-MRI) and atherosclerotic protein examinations from May 2015 to December 2021 were collected. A CRstalk (signal intensity [SI] of IFA wall/SI of pituitary stalk) > 0.60 was considered to indicate AWE. Atherosclerotic protein data was obtained from the peripheral blood. Aneurysmal characteristics included the maximal diameter of the cross-section (Dmax), location, type of IFA, presence of mural thrombus, and mural clots. Statistical analyses were performed with univariate analysis, logistic regression analysis, and Spearman's correlation coefficient.
RESULTS: Seventy-one IFAs from 71 patients were included in the study. Multivariate analysis revealed statin use (OR = 0.189, p = 0.026) and apolipoprotein B (Apo-B) level (OR = 6.019, p = 0.026) were the independent predictors of AWE in IFAs. In addition, statin use (OR = 0.813, p = 0.036) and Apo-B level (OR = 1.610, p = 0.003) were also the independent predictors of CRstalk. Additionally, we found that CRstalk and AWE were significantly positively associated with Dmax (rs = 0.409 and 0.349, respectively; p < 0.001 and p = 0.003, respectively).
CONCLUSIONS: There may be correlations between AWE, atherosclerotic protein levels, and aneurysm size in patients with IFAs. Apo-B and statin use were independent predictors of AWE in IFAs, which have the potential to be new therapeutic targets for IFAs.
KEY POINTS: • There may be correlations between aneurysm wall enhancement, atherosclerotic protein levels in the peripheral blood, and aneurysm size in patients with intracranial fusiform aneurysms. • Apolipoprotein B and statin use were independent predictors of aneurysm wall enhancement in intracranial fusiform aneurysms.
引用
- Peng, Niu, Feng, et al. Aneurysm wall enhancement, atherosclerotic proteins, and aneurysm size may be related in unruptured intracranial fusiform aneurysms. Eur Radiol. 2023. PMID: 36840766. doi:10.1007/s00330-023-09456-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。